SCHEMBL6429647

SCHEMBL6429647

COc1ccc(S(=O)(=O)N2CCc3ccccc3C2)cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 1.00
CYP2C19 P33261 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
USP2 O75604 2/20 0.66
TSHR P16473 2/20 0.66
PDE4A P27815 1/20 0.65
PDE4B Q07343 1/20 0.65
PDE4C Q08493 1/20 0.65
PDE4D Q08499 1/20 0.65
PKM P14618 3/20 0.63
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
RAB9A P51151 2/20 0.61
GPBAR1 Q8TDU6 1/20 0.60
LMNA P02545 2/20 0.58
MAPK1 P28482 2/20 0.58
GLA P06280 1/20 0.58
HSD17B10 Q99714 1/20 0.58
AKR1C3 P42330 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27408461 0.85 CYP3A4 (0.73) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL3284893 0.82 AKR1C3 (0.71) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL4184681 0.80 GPBAR1 (0.90) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL3830421 0.80 GPBAR1 (0.90) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL6445534 0.80 MEN1 (0.78) CYP3A4CYP2C19SMN1; SMN2NPSR1PKM
SCHEMBL6449603 0.80 ALDH1A1 (0.67) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL4187995 0.79 GPBAR1 (0.73) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL6977881 0.79 GPBAR1 (0.73) CYP3A4CYP2C19SMN1; SMN2NPSR1USP2
SCHEMBL7356297 0.79 PDE4A (1.00) CYP3A4CYP2C19SMN1; SMN2NPSR1TSHR
SCHEMBL8589869 0.78 MEN1 (0.68) CYP3A4CYP2C19SMN1; SMN2NPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001764-A4 HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS MERCK & CO INC (US) 2005-08-24 EP claimed
JP-2002512625-A 2002-04-23 JP claimed
EP-1001764-A1 HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS Merck & Co., Inc. (a New Jersey corp.) (US) 2000-05-24 EP claimed
WO-1999064395-A1 HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 1999-12-16 WO claimed
WO-1998053814-A1 HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 1998-12-03 WO claimed
US-5728712-A 3,4-disubstituted-phenylsulphonamides and their therapeutic use CHIROSCIENCE LIMITED (GB) 1998-03-17 US claimed
US-5728712-A 3,4-disubstituted-phenylsulphonamides and their therapeutic use CHIROSCIENCE LIMITED (GB) 1998-03-17 US disclosed